Cargando…
Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from tw...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800278/ https://www.ncbi.nlm.nih.gov/pubmed/35090428 http://dx.doi.org/10.1186/s12885-022-09207-x |
_version_ | 1784642226055282688 |
---|---|
author | Wu, Lei-Lei Zhong, Jiu-Di Zhu, Jia-Li Kang, Lu Huang, Yang-Yu Lin, Peng Long, Hao Zhang, Lan-Jun Ma, Qi-Long Qiu, Li-Hong Ma, Guo-Wei |
author_facet | Wu, Lei-Lei Zhong, Jiu-Di Zhu, Jia-Li Kang, Lu Huang, Yang-Yu Lin, Peng Long, Hao Zhang, Lan-Jun Ma, Qi-Long Qiu, Li-Hong Ma, Guo-Wei |
author_sort | Wu, Lei-Lei |
collection | PubMed |
description | BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from two cancer databases—our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. RESULTS: X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445–0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). CONCLUSIONS: The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1–3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15–30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies. |
format | Online Article Text |
id | pubmed-8800278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88002782022-02-02 Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 Wu, Lei-Lei Zhong, Jiu-Di Zhu, Jia-Li Kang, Lu Huang, Yang-Yu Lin, Peng Long, Hao Zhang, Lan-Jun Ma, Qi-Long Qiu, Li-Hong Ma, Guo-Wei BMC Cancer Research BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from two cancer databases—our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. RESULTS: X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445–0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). CONCLUSIONS: The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1–3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15–30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies. BioMed Central 2022-01-28 /pmc/articles/PMC8800278/ /pubmed/35090428 http://dx.doi.org/10.1186/s12885-022-09207-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wu, Lei-Lei Zhong, Jiu-Di Zhu, Jia-Li Kang, Lu Huang, Yang-Yu Lin, Peng Long, Hao Zhang, Lan-Jun Ma, Qi-Long Qiu, Li-Hong Ma, Guo-Wei Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title | Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title_full | Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title_fullStr | Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title_full_unstemmed | Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title_short | Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 |
title_sort | postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage t1–3n0m0 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800278/ https://www.ncbi.nlm.nih.gov/pubmed/35090428 http://dx.doi.org/10.1186/s12885-022-09207-x |
work_keys_str_mv | AT wuleilei postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT zhongjiudi postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT zhujiali postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT kanglu postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT huangyangyu postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT linpeng postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT longhao postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT zhanglanjun postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT maqilong postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT qiulihong postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 AT maguowei postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0 |